Improved liver transplant outcomes for patients with hilar cholangiocarcinoma following implementation of the MMAT-3 policy

By afschroeder • November 18, 2025

Shaikh A, Lee TH, Lymberopoulos P, Benhammou JN, Rich N, Agopian VG, Hernaez R, Goss J, Singal AG, El-Serag HB, Rana A, Kanwal F, Berg C, Cholankeril G. Improved liver transplant outcomes for patients with hilar cholangiocarcinoma following implementation of the MMAT-3 policy. Liver Transpl. 2025 Nov 6. doi: 10.1097/LVT.0000000000000768. Epub ahead of print. PMID: 41248258.

Tags: Digestive Diseases, Hepatocellular carcinoma, hilar cholangiocarcinoma, liver transplant, MMAT, Publications, transplant policy, Veterans Administration

JPEN Journal Club 97. Splitting studies

Koretz RL. JPEN Journal Club 97. Splitting studies. JPEN J Parenter Enteral Nutr. 2025 Nov 16. doi: 10.1002/jpen.70035. Epub ahead of print. PMID: 41241824.

Characterization of the Fecal Metabolome in Patients With Early Systemic Sclerosis

Young AC, Andréasson K, Labus J, Matulionis N, Jacobs JP, Christofk H, Volkmann ER. Characterization of the Fecal Metabolome in Patients With Early Systemic Sclerosis.[...]

Outcomes from Referral to Transplant for Patients with MASLD: A California Liver Network Study

Lim TY, Steggerda JA, Trivedi H, Luu M, Vipani A, Adjei MA, Singh J, Zhou K, Kwong A, Tincopa M, Vodkin I, Ajmera V, Mehta[...]